Miohere Investment Group (MIG) is a group company focusing on investing in the health care industry. It has 10 branches and 13 development centers all over the country. Miphere Investment Group is a high-tech company dedicated to investing in China's high-end medical imaging diagnostics and treatment market, including project management, technical consultancy, new technology promotion, equipment financing leasing, nuclear medical imaging agent production, research and development, and transformation of medical investment. Since it entered the Chinese medical market in 2003, it has successfully provided consulting and post-operation services for PET-CT centers, cyclotrons and radiotherapy centers in many well-known hospitals in China. With its rich market resources and nationwide service network, and with the cooperation of medical authorities and pioneers, Miphere is making great strides in the research and development of the world's top medical imaging diagnostic equipment, PET-CT, PET-MRI and its imaging agents, as well as in the field of translational medicine.

Following the trend of the industry and making full use of the advantages of domestic and foreign resources, we will build a large-scale medical network service and education platform in Greater China, which is centered on large-scale data processing and based on high-efficiency mobile network operation mode and high-end imaging diagnosis and treatment center. The platform aims to apply the most advanced diagnostic and therapeutic technologies to prolong the lives of patients with major diseases, reduce the suffering of patients, and improve the quality of life of patients, thus creating an advanced medical and health industry chain suitable for China's national conditions, and realizing education to health care, work to health care through cross-regional and cross-industry investment exchanges and cooperation. And the whole life cycle of humanized service system, such as home care.

Miphere has been working hard.